/Viatris%20Inc%20logo%20on%20building-by%20SSKH-Pictures%20via%20Shutterstock.jpg)
Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, operates as a healthcare company. With a market cap of $12.1 billion, the company produces medicines for patients across a broad range of major therapeutic areas spanning both noncommunicable and infectious diseases. The global healthcare giant is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Thursday, Nov. 6.
Ahead of the event, analysts expect VTRS to report a profit of $0.63 per share on a diluted basis, down 16% from $0.75 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion.